In Vivo Assessment of Astrocyte Reactivity in Patients with Progressive Supranuclear Palsy

Objective Although astrocytic pathology is a pathological hallmark of progressive supranuclear palsy (PSP), its pathophysiological role remains unclear. This study aimed to assess astrocyte reactivity in vivo in patients with PSP. Furthermore, we investigated alterations in brain lactate levels and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of neurology 2024-08, Vol.96 (2), p.247-261
Hauptverfasser: Hirata, Kosei, Matsuoka, Kiwamu, Tagai, Kenji, Endo, Hironobu, Tatebe, Harutsugu, Ono, Maiko, Kokubo, Naomi, Kataoka, Yuko, Oyama, Asaka, Shinotoh, Hitoshi, Takahata, Keisuke, Obata, Takayuki, Dehghani, Masoumeh, Near, Jamie, Kawamura, Kazunori, Zhang, Ming‐Rong, Shimada, Hitoshi, Shimizu, Hiroshi, Kakita, Akiyoshi, Yokota, Takanori, Tokuda, Takahiko, Higuchi, Makoto, Takado, Yuhei
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 261
container_issue 2
container_start_page 247
container_title Annals of neurology
container_volume 96
creator Hirata, Kosei
Matsuoka, Kiwamu
Tagai, Kenji
Endo, Hironobu
Tatebe, Harutsugu
Ono, Maiko
Kokubo, Naomi
Kataoka, Yuko
Oyama, Asaka
Shinotoh, Hitoshi
Takahata, Keisuke
Obata, Takayuki
Dehghani, Masoumeh
Near, Jamie
Kawamura, Kazunori
Zhang, Ming‐Rong
Shimada, Hitoshi
Shimizu, Hiroshi
Kakita, Akiyoshi
Yokota, Takanori
Tokuda, Takahiko
Higuchi, Makoto
Takado, Yuhei
description Objective Although astrocytic pathology is a pathological hallmark of progressive supranuclear palsy (PSP), its pathophysiological role remains unclear. This study aimed to assess astrocyte reactivity in vivo in patients with PSP. Furthermore, we investigated alterations in brain lactate levels and their relationship with astrocyte reactivity. Methods We included 30 patients with PSP‐Richardson syndrome and 30 healthy controls; in patients, tau deposition was confirmed through 18F‐florzolotau positron emission tomography. Myo‐inositol, an astroglial marker, and lactate were quantified in the anterior cingulate cortex through magnetic resonance spectroscopy. We measured plasma biomarkers, including glial fibrillary acidic protein as another astrocytic marker. The anterior cingulate cortex was histologically assessed in postmortem samples of another 3 patients with PSP with comparable disease durations. Results The levels of myo‐inositol and plasma glial fibrillary acidic protein were significantly higher in patients than those in healthy controls (p 
doi_str_mv 10.1002/ana.26962
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3057693433</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3077712319</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3482-101f60420dea95e3094e5e3ea5ed4db304b0e5f1ac5f8e9f18ef693c546346303</originalsourceid><addsrcrecordid>eNp10F1LwzAUBuAgipvTC_-ABLzRi24nTZq2l2P4MRg6_LrwpmTtqWZ07Uzajf57o51eCELgEHjOy-El5JTBkAH4I1WqoS9j6e-RPgs48yJfxPukD1wKL2Bc9MiRtUsAiCWDQ9LjURgykLJPXqclfdGbio6tRWtXWNa0yt2vNlXa1kgfUKW13ui6pbqkc1VrRyzd6vqdzk31ZtyW3iB9bNZGlU1aoDKOFbY9Jge5m3iymwPyfH31NLn1Zvc308l45qVcRL7HgOUShA8ZqjhADrFAN1AFmIlswUEsAIOcqTTII4xzFmEuY54GQnL3gA_IRZe7NtVHg7ZOVtqmWBSqxKqxCYcgdAuCc0fP_9Bl1ZjSXedU6DrxOYuduuxUaiprDebJ2uiVMm3CIPkqPHGFJ9-FO3u2S2wWK8x-5U_DDow6sNUFtv8nJeO7cRf5CRZpiXw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3077712319</pqid></control><display><type>article</type><title>In Vivo Assessment of Astrocyte Reactivity in Patients with Progressive Supranuclear Palsy</title><source>Access via Wiley Online Library</source><creator>Hirata, Kosei ; Matsuoka, Kiwamu ; Tagai, Kenji ; Endo, Hironobu ; Tatebe, Harutsugu ; Ono, Maiko ; Kokubo, Naomi ; Kataoka, Yuko ; Oyama, Asaka ; Shinotoh, Hitoshi ; Takahata, Keisuke ; Obata, Takayuki ; Dehghani, Masoumeh ; Near, Jamie ; Kawamura, Kazunori ; Zhang, Ming‐Rong ; Shimada, Hitoshi ; Shimizu, Hiroshi ; Kakita, Akiyoshi ; Yokota, Takanori ; Tokuda, Takahiko ; Higuchi, Makoto ; Takado, Yuhei</creator><creatorcontrib>Hirata, Kosei ; Matsuoka, Kiwamu ; Tagai, Kenji ; Endo, Hironobu ; Tatebe, Harutsugu ; Ono, Maiko ; Kokubo, Naomi ; Kataoka, Yuko ; Oyama, Asaka ; Shinotoh, Hitoshi ; Takahata, Keisuke ; Obata, Takayuki ; Dehghani, Masoumeh ; Near, Jamie ; Kawamura, Kazunori ; Zhang, Ming‐Rong ; Shimada, Hitoshi ; Shimizu, Hiroshi ; Kakita, Akiyoshi ; Yokota, Takanori ; Tokuda, Takahiko ; Higuchi, Makoto ; Takado, Yuhei</creatorcontrib><description>Objective Although astrocytic pathology is a pathological hallmark of progressive supranuclear palsy (PSP), its pathophysiological role remains unclear. This study aimed to assess astrocyte reactivity in vivo in patients with PSP. Furthermore, we investigated alterations in brain lactate levels and their relationship with astrocyte reactivity. Methods We included 30 patients with PSP‐Richardson syndrome and 30 healthy controls; in patients, tau deposition was confirmed through 18F‐florzolotau positron emission tomography. Myo‐inositol, an astroglial marker, and lactate were quantified in the anterior cingulate cortex through magnetic resonance spectroscopy. We measured plasma biomarkers, including glial fibrillary acidic protein as another astrocytic marker. The anterior cingulate cortex was histologically assessed in postmortem samples of another 3 patients with PSP with comparable disease durations. Results The levels of myo‐inositol and plasma glial fibrillary acidic protein were significantly higher in patients than those in healthy controls (p &lt; 0.05); these increases were significantly associated with PSP rating scale and cognitive function scores (p &lt; 0.05). The lactate level was high in patients, and correlated significantly with high myo‐inositol levels. Histological analysis of the anterior cingulate cortex in patients revealed reactive astrocytes, despite mild tau deposition, and no marked synaptic loss. Interpretation We discovered high levels of astrocyte biomarkers in patients with PSP, suggesting astrocyte reactivity. The association between myo‐inositol and lactate levels suggests a link between reactive astrocytes and brain energy metabolism changes. Our results indicate that astrocyte reactivity in the anterior cingulate cortex precedes pronounced tau pathology and neurodegenerative processes in that region, and affects brain function in PSP. ANN NEUROL 2024;96:247–261</description><identifier>ISSN: 0364-5134</identifier><identifier>ISSN: 1531-8249</identifier><identifier>EISSN: 1531-8249</identifier><identifier>DOI: 10.1002/ana.26962</identifier><identifier>PMID: 38771066</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><subject>Astrocytes ; Biomarkers ; Brain ; Cognitive ability ; Cortex (cingulate) ; Deposition ; Disease control ; Energy metabolism ; Glial fibrillary acidic protein ; In vivo methods and tests ; Inositol ; Inositols ; Lactic acid ; Magnetic resonance spectroscopy ; Pathology ; Positron emission ; Positron emission tomography ; Progressive supranuclear palsy ; Proteins ; Tau protein</subject><ispartof>Annals of neurology, 2024-08, Vol.96 (2), p.247-261</ispartof><rights>2024 The Authors. published by Wiley Periodicals LLC on behalf of American Neurological Association.</rights><rights>2024 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.</rights><rights>2024. This article is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3482-101f60420dea95e3094e5e3ea5ed4db304b0e5f1ac5f8e9f18ef693c546346303</cites><orcidid>0009-0007-9027-9277 ; 0000-0001-7484-8424 ; 0000-0002-5131-1533</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fana.26962$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fana.26962$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>315,781,785,1418,27928,27929,45578,45579</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38771066$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hirata, Kosei</creatorcontrib><creatorcontrib>Matsuoka, Kiwamu</creatorcontrib><creatorcontrib>Tagai, Kenji</creatorcontrib><creatorcontrib>Endo, Hironobu</creatorcontrib><creatorcontrib>Tatebe, Harutsugu</creatorcontrib><creatorcontrib>Ono, Maiko</creatorcontrib><creatorcontrib>Kokubo, Naomi</creatorcontrib><creatorcontrib>Kataoka, Yuko</creatorcontrib><creatorcontrib>Oyama, Asaka</creatorcontrib><creatorcontrib>Shinotoh, Hitoshi</creatorcontrib><creatorcontrib>Takahata, Keisuke</creatorcontrib><creatorcontrib>Obata, Takayuki</creatorcontrib><creatorcontrib>Dehghani, Masoumeh</creatorcontrib><creatorcontrib>Near, Jamie</creatorcontrib><creatorcontrib>Kawamura, Kazunori</creatorcontrib><creatorcontrib>Zhang, Ming‐Rong</creatorcontrib><creatorcontrib>Shimada, Hitoshi</creatorcontrib><creatorcontrib>Shimizu, Hiroshi</creatorcontrib><creatorcontrib>Kakita, Akiyoshi</creatorcontrib><creatorcontrib>Yokota, Takanori</creatorcontrib><creatorcontrib>Tokuda, Takahiko</creatorcontrib><creatorcontrib>Higuchi, Makoto</creatorcontrib><creatorcontrib>Takado, Yuhei</creatorcontrib><title>In Vivo Assessment of Astrocyte Reactivity in Patients with Progressive Supranuclear Palsy</title><title>Annals of neurology</title><addtitle>Ann Neurol</addtitle><description>Objective Although astrocytic pathology is a pathological hallmark of progressive supranuclear palsy (PSP), its pathophysiological role remains unclear. This study aimed to assess astrocyte reactivity in vivo in patients with PSP. Furthermore, we investigated alterations in brain lactate levels and their relationship with astrocyte reactivity. Methods We included 30 patients with PSP‐Richardson syndrome and 30 healthy controls; in patients, tau deposition was confirmed through 18F‐florzolotau positron emission tomography. Myo‐inositol, an astroglial marker, and lactate were quantified in the anterior cingulate cortex through magnetic resonance spectroscopy. We measured plasma biomarkers, including glial fibrillary acidic protein as another astrocytic marker. The anterior cingulate cortex was histologically assessed in postmortem samples of another 3 patients with PSP with comparable disease durations. Results The levels of myo‐inositol and plasma glial fibrillary acidic protein were significantly higher in patients than those in healthy controls (p &lt; 0.05); these increases were significantly associated with PSP rating scale and cognitive function scores (p &lt; 0.05). The lactate level was high in patients, and correlated significantly with high myo‐inositol levels. Histological analysis of the anterior cingulate cortex in patients revealed reactive astrocytes, despite mild tau deposition, and no marked synaptic loss. Interpretation We discovered high levels of astrocyte biomarkers in patients with PSP, suggesting astrocyte reactivity. The association between myo‐inositol and lactate levels suggests a link between reactive astrocytes and brain energy metabolism changes. Our results indicate that astrocyte reactivity in the anterior cingulate cortex precedes pronounced tau pathology and neurodegenerative processes in that region, and affects brain function in PSP. ANN NEUROL 2024;96:247–261</description><subject>Astrocytes</subject><subject>Biomarkers</subject><subject>Brain</subject><subject>Cognitive ability</subject><subject>Cortex (cingulate)</subject><subject>Deposition</subject><subject>Disease control</subject><subject>Energy metabolism</subject><subject>Glial fibrillary acidic protein</subject><subject>In vivo methods and tests</subject><subject>Inositol</subject><subject>Inositols</subject><subject>Lactic acid</subject><subject>Magnetic resonance spectroscopy</subject><subject>Pathology</subject><subject>Positron emission</subject><subject>Positron emission tomography</subject><subject>Progressive supranuclear palsy</subject><subject>Proteins</subject><subject>Tau protein</subject><issn>0364-5134</issn><issn>1531-8249</issn><issn>1531-8249</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><recordid>eNp10F1LwzAUBuAgipvTC_-ABLzRi24nTZq2l2P4MRg6_LrwpmTtqWZ07Uzajf57o51eCELgEHjOy-El5JTBkAH4I1WqoS9j6e-RPgs48yJfxPukD1wKL2Bc9MiRtUsAiCWDQ9LjURgykLJPXqclfdGbio6tRWtXWNa0yt2vNlXa1kgfUKW13ui6pbqkc1VrRyzd6vqdzk31ZtyW3iB9bNZGlU1aoDKOFbY9Jge5m3iymwPyfH31NLn1Zvc308l45qVcRL7HgOUShA8ZqjhADrFAN1AFmIlswUEsAIOcqTTII4xzFmEuY54GQnL3gA_IRZe7NtVHg7ZOVtqmWBSqxKqxCYcgdAuCc0fP_9Bl1ZjSXedU6DrxOYuduuxUaiprDebJ2uiVMm3CIPkqPHGFJ9-FO3u2S2wWK8x-5U_DDow6sNUFtv8nJeO7cRf5CRZpiXw</recordid><startdate>202408</startdate><enddate>202408</enddate><creator>Hirata, Kosei</creator><creator>Matsuoka, Kiwamu</creator><creator>Tagai, Kenji</creator><creator>Endo, Hironobu</creator><creator>Tatebe, Harutsugu</creator><creator>Ono, Maiko</creator><creator>Kokubo, Naomi</creator><creator>Kataoka, Yuko</creator><creator>Oyama, Asaka</creator><creator>Shinotoh, Hitoshi</creator><creator>Takahata, Keisuke</creator><creator>Obata, Takayuki</creator><creator>Dehghani, Masoumeh</creator><creator>Near, Jamie</creator><creator>Kawamura, Kazunori</creator><creator>Zhang, Ming‐Rong</creator><creator>Shimada, Hitoshi</creator><creator>Shimizu, Hiroshi</creator><creator>Kakita, Akiyoshi</creator><creator>Yokota, Takanori</creator><creator>Tokuda, Takahiko</creator><creator>Higuchi, Makoto</creator><creator>Takado, Yuhei</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>WIN</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7U7</scope><scope>C1K</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0009-0007-9027-9277</orcidid><orcidid>https://orcid.org/0000-0001-7484-8424</orcidid><orcidid>https://orcid.org/0000-0002-5131-1533</orcidid></search><sort><creationdate>202408</creationdate><title>In Vivo Assessment of Astrocyte Reactivity in Patients with Progressive Supranuclear Palsy</title><author>Hirata, Kosei ; Matsuoka, Kiwamu ; Tagai, Kenji ; Endo, Hironobu ; Tatebe, Harutsugu ; Ono, Maiko ; Kokubo, Naomi ; Kataoka, Yuko ; Oyama, Asaka ; Shinotoh, Hitoshi ; Takahata, Keisuke ; Obata, Takayuki ; Dehghani, Masoumeh ; Near, Jamie ; Kawamura, Kazunori ; Zhang, Ming‐Rong ; Shimada, Hitoshi ; Shimizu, Hiroshi ; Kakita, Akiyoshi ; Yokota, Takanori ; Tokuda, Takahiko ; Higuchi, Makoto ; Takado, Yuhei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3482-101f60420dea95e3094e5e3ea5ed4db304b0e5f1ac5f8e9f18ef693c546346303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Astrocytes</topic><topic>Biomarkers</topic><topic>Brain</topic><topic>Cognitive ability</topic><topic>Cortex (cingulate)</topic><topic>Deposition</topic><topic>Disease control</topic><topic>Energy metabolism</topic><topic>Glial fibrillary acidic protein</topic><topic>In vivo methods and tests</topic><topic>Inositol</topic><topic>Inositols</topic><topic>Lactic acid</topic><topic>Magnetic resonance spectroscopy</topic><topic>Pathology</topic><topic>Positron emission</topic><topic>Positron emission tomography</topic><topic>Progressive supranuclear palsy</topic><topic>Proteins</topic><topic>Tau protein</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hirata, Kosei</creatorcontrib><creatorcontrib>Matsuoka, Kiwamu</creatorcontrib><creatorcontrib>Tagai, Kenji</creatorcontrib><creatorcontrib>Endo, Hironobu</creatorcontrib><creatorcontrib>Tatebe, Harutsugu</creatorcontrib><creatorcontrib>Ono, Maiko</creatorcontrib><creatorcontrib>Kokubo, Naomi</creatorcontrib><creatorcontrib>Kataoka, Yuko</creatorcontrib><creatorcontrib>Oyama, Asaka</creatorcontrib><creatorcontrib>Shinotoh, Hitoshi</creatorcontrib><creatorcontrib>Takahata, Keisuke</creatorcontrib><creatorcontrib>Obata, Takayuki</creatorcontrib><creatorcontrib>Dehghani, Masoumeh</creatorcontrib><creatorcontrib>Near, Jamie</creatorcontrib><creatorcontrib>Kawamura, Kazunori</creatorcontrib><creatorcontrib>Zhang, Ming‐Rong</creatorcontrib><creatorcontrib>Shimada, Hitoshi</creatorcontrib><creatorcontrib>Shimizu, Hiroshi</creatorcontrib><creatorcontrib>Kakita, Akiyoshi</creatorcontrib><creatorcontrib>Yokota, Takanori</creatorcontrib><creatorcontrib>Tokuda, Takahiko</creatorcontrib><creatorcontrib>Higuchi, Makoto</creatorcontrib><creatorcontrib>Takado, Yuhei</creatorcontrib><collection>Wiley Online Library (Open Access Collection)</collection><collection>Wiley Online Library (Open Access Collection)</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hirata, Kosei</au><au>Matsuoka, Kiwamu</au><au>Tagai, Kenji</au><au>Endo, Hironobu</au><au>Tatebe, Harutsugu</au><au>Ono, Maiko</au><au>Kokubo, Naomi</au><au>Kataoka, Yuko</au><au>Oyama, Asaka</au><au>Shinotoh, Hitoshi</au><au>Takahata, Keisuke</au><au>Obata, Takayuki</au><au>Dehghani, Masoumeh</au><au>Near, Jamie</au><au>Kawamura, Kazunori</au><au>Zhang, Ming‐Rong</au><au>Shimada, Hitoshi</au><au>Shimizu, Hiroshi</au><au>Kakita, Akiyoshi</au><au>Yokota, Takanori</au><au>Tokuda, Takahiko</au><au>Higuchi, Makoto</au><au>Takado, Yuhei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>In Vivo Assessment of Astrocyte Reactivity in Patients with Progressive Supranuclear Palsy</atitle><jtitle>Annals of neurology</jtitle><addtitle>Ann Neurol</addtitle><date>2024-08</date><risdate>2024</risdate><volume>96</volume><issue>2</issue><spage>247</spage><epage>261</epage><pages>247-261</pages><issn>0364-5134</issn><issn>1531-8249</issn><eissn>1531-8249</eissn><abstract>Objective Although astrocytic pathology is a pathological hallmark of progressive supranuclear palsy (PSP), its pathophysiological role remains unclear. This study aimed to assess astrocyte reactivity in vivo in patients with PSP. Furthermore, we investigated alterations in brain lactate levels and their relationship with astrocyte reactivity. Methods We included 30 patients with PSP‐Richardson syndrome and 30 healthy controls; in patients, tau deposition was confirmed through 18F‐florzolotau positron emission tomography. Myo‐inositol, an astroglial marker, and lactate were quantified in the anterior cingulate cortex through magnetic resonance spectroscopy. We measured plasma biomarkers, including glial fibrillary acidic protein as another astrocytic marker. The anterior cingulate cortex was histologically assessed in postmortem samples of another 3 patients with PSP with comparable disease durations. Results The levels of myo‐inositol and plasma glial fibrillary acidic protein were significantly higher in patients than those in healthy controls (p &lt; 0.05); these increases were significantly associated with PSP rating scale and cognitive function scores (p &lt; 0.05). The lactate level was high in patients, and correlated significantly with high myo‐inositol levels. Histological analysis of the anterior cingulate cortex in patients revealed reactive astrocytes, despite mild tau deposition, and no marked synaptic loss. Interpretation We discovered high levels of astrocyte biomarkers in patients with PSP, suggesting astrocyte reactivity. The association between myo‐inositol and lactate levels suggests a link between reactive astrocytes and brain energy metabolism changes. Our results indicate that astrocyte reactivity in the anterior cingulate cortex precedes pronounced tau pathology and neurodegenerative processes in that region, and affects brain function in PSP. ANN NEUROL 2024;96:247–261</abstract><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>38771066</pmid><doi>10.1002/ana.26962</doi><tpages>15</tpages><orcidid>https://orcid.org/0009-0007-9027-9277</orcidid><orcidid>https://orcid.org/0000-0001-7484-8424</orcidid><orcidid>https://orcid.org/0000-0002-5131-1533</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0364-5134
ispartof Annals of neurology, 2024-08, Vol.96 (2), p.247-261
issn 0364-5134
1531-8249
1531-8249
language eng
recordid cdi_proquest_miscellaneous_3057693433
source Access via Wiley Online Library
subjects Astrocytes
Biomarkers
Brain
Cognitive ability
Cortex (cingulate)
Deposition
Disease control
Energy metabolism
Glial fibrillary acidic protein
In vivo methods and tests
Inositol
Inositols
Lactic acid
Magnetic resonance spectroscopy
Pathology
Positron emission
Positron emission tomography
Progressive supranuclear palsy
Proteins
Tau protein
title In Vivo Assessment of Astrocyte Reactivity in Patients with Progressive Supranuclear Palsy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T13%3A36%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=In%20Vivo%20Assessment%20of%20Astrocyte%20Reactivity%20in%20Patients%20with%20Progressive%20Supranuclear%20Palsy&rft.jtitle=Annals%20of%20neurology&rft.au=Hirata,%20Kosei&rft.date=2024-08&rft.volume=96&rft.issue=2&rft.spage=247&rft.epage=261&rft.pages=247-261&rft.issn=0364-5134&rft.eissn=1531-8249&rft_id=info:doi/10.1002/ana.26962&rft_dat=%3Cproquest_cross%3E3077712319%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3077712319&rft_id=info:pmid/38771066&rfr_iscdi=true